Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-26-182140
Filing Date
2026-04-27
Accepted
2026-04-27 16:18:09
Documents
13
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A tern-20251231.htm   iXBRL 10-K/A 906038
2 EX-31.3 tern-ex31_3.htm EX-31.3 11145
3 EX-31.4 tern-ex31_4.htm EX-31.4 11128
  Complete submission text file 0001193125-26-182140.txt   3726848

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tern-20251231.xsd EX-101.SCH 1817504
17 EXTRACTED XBRL INSTANCE DOCUMENT tern-20251231_htm.xml XML 15019
Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Filer) CIK: 0001831363 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39926 | Film No.: 26901304
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)